In the last trading session, 1.36 million Ekso Bionics Holdings Inc (NASDAQ:EKSO) shares changed hands as the company’s beta touched 1.47. With the company’s per share price at $0.79 changed hands at $0.09 or 12.70% during last session, the market valuation stood at $17.36M. EKSO’s last price was a discount, traded about -283.54% off its 52-week high of $3.03. The share price had its 52-week low at $0.50, which suggests the last value was 36.71% up since then. When we look at Ekso Bionics Holdings Inc’s average trading volume, we note the 10-day average is 5.35 million shares, with the 3-month average coming to 918.58K.
Analysts gave the Ekso Bionics Holdings Inc (EKSO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended EKSO as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Ekso Bionics Holdings Inc’s EPS for the current quarter is expected to be 0.
Ekso Bionics Holdings Inc (NASDAQ:EKSO) trade information
Instantly EKSO was in green as seen at the end of in last trading. With action 26.75%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 29.34%, with the 5-day performance at 26.75% in the green. However, in the 30-day time frame, Ekso Bionics Holdings Inc (NASDAQ:EKSO) is 13.20% up. Looking at the short shares, we see there were 0.12 million shares sold at short interest cover period of 1.07 days.
The consensus price target for the stock as assigned by Wall Street analysts is 2, meaning bulls need an upside of 60.5% from its current market value. According to analyst projections, EKSO’s forecast low is 2 with 2 as the target high. To hit the forecast high, the stock’s price needs a -153.16% plunge from its current level, while the stock would need to soar -153.16% for it to hit the projected low.
Ekso Bionics Holdings Inc (EKSO) estimates and forecasts
Data shows that the Ekso Bionics Holdings Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -30.18% over the past 6 months, a 56.36% in annual growth rate that is considerably higher than the industry average of 14.90%. Year-over-year growth is forecast to reach -0.87% down from the last financial year.
Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of 5.3M. 2 analysts are of the opinion that Ekso Bionics Holdings Inc’s revenue for the current quarter will be 5.05M. The company’s revenue for the corresponding quarters a year ago was 4.85M and 3.76M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 9.40%. The estimates for the next quarter sales put growth at 34.45%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 30.19%. The 2025 estimates are for Ekso Bionics Holdings Inc earnings to increase by 55.45%.
EKSO Dividends
Ekso Bionics Holdings Inc is expected to release its next quarterly earnings report in February.
Ekso Bionics Holdings Inc (NASDAQ:EKSO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 7.91% of Ekso Bionics Holdings Inc shares while 25.25% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 27.42%. There are 25.25% institutions holding the Ekso Bionics Holdings Inc stock share, with KENT LAKE CAPITAL LLC the top institutional holder. As of 2024-06-30, the company held 3.9959% of the shares, roughly 0.7 million EKSO shares worth $0.73 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 3.4125% or 0.59 million shares worth $0.63 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . With 400.89 shares estimated at $0.32 million under it, the former controlled 1.82% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.82% of the shares, roughly 179.46 shares worth around $0.14 million.
